Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
2
Bearish filings
21
Named actors
10
Disclosed $ (bull / bear)
size unknown / $4.3M + 2 of unknown size
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-05-15 | 5%+ holder (13G) RA CAPITAL MANAGEMENT, L.P. | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-08 | 5%+ holder (13G) PRICE T ROWE ASSOCIATES INC /MD/ | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-01-21 | Chief Human Resources Officer McCarthy Teresa | sold | $107K | SEC ↗ |
| 2026-01-21 | Chief Human Resources Officer McCarthy Teresa | sold | $105K | SEC ↗ |
| 2026-01-21 | Director LEVIN ARTHUR A | sold | $127K | SEC ↗ |
Want the read, not just the record?
Members see how notable each move is, the actor's past track record, cross-source convergence, and alerts on this name.
Start free — 1 week, no card →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-01-21 | Chief Financial Officer MacLean Michael F | sold | $198K | SEC ↗ |
| 2026-01-21 | Chief Financial Officer MacLean Michael F | sold | $131K | SEC ↗ |
| 2026-01-21 | Chief Scientific Officer Flanagan W. Michael | sold | $185K | SEC ↗ |
| 2026-01-21 | Chief Scientific Officer Flanagan W. Michael | sold | $288K | SEC ↗ |
| 2026-01-21 | President and CEO Boyce Sarah | sold | $463K | SEC ↗ |
| 2026-01-21 | President and CEO Boyce Sarah | sold | $579K | SEC ↗ |
| 2026-01-21 | Chief Medical Officer Hughes Steven George | sold | $209K | SEC ↗ |
| 2026-01-21 | Chief Medical Officer Hughes Steven George | sold | $146K | SEC ↗ |
| 2026-01-07 | Chief Scientific Officer Flanagan W. Michael | sold | $171K | SEC ↗ |
| 2026-01-07 | Chief Medical Officer Hughes Steven George | sold | $171K | SEC ↗ |
| 2026-01-07 | Chief Financial Officer MacLean Michael F | sold | $143K | SEC ↗ |
| 2026-01-07 | Chief Legal Officer Moriarty John B | sold | $171K | SEC ↗ |
| 2026-01-07 | Chief Human Resources Officer McCarthy Teresa | sold | $142K | SEC ↗ |
| 2026-01-07 | Chief Technical Officer Calderaro Charles III | sold | $269K | SEC ↗ |
| 2026-01-07 | President and CEO Boyce Sarah | sold | $619K | SEC ↗ |
| 2025-12-19 | Director LEVIN ARTHUR A | gifted | — | SEC ↗ |
| 2025-12-18 | President and CEO Boyce Sarah | gifted | — | SEC ↗ |
| 2025-10-22 | Chief Medical Officer Hughes Steven George | sold | $105K | SEC ↗ |